Altimmune ALT
NASDAQ ALT
$3.38 +0.14 (+4.49%)
As of: Sep 4, 2026 · 2:28 PM EDT

Altimmune (ALT) Preferred Dividend Payments (2016 - 2019)

Altimmune (ALT) posted quarterly Preferred Dividend Payments of $452925.0 for Q1 2019, down 76.05% year-over-year from $1.9 million in Q1 2018, and down 41.97% quarter-over-quarter from $780525.0 in Q4 2018.

Analysis

Altimmune (ALT) Preferred Dividend Payments (2016 - 2019) Analysis & Trends

Altimmune (ALT) has reported Preferred Dividend Payments for 4 consecutive years, with $452925.0 the latest figure, recorded in Q1 2019.

  • In Q1 2019, Preferred Dividend Payments fell 76.05% year-over-year to $452925.0; the TTM figure through Dec 2019 stood at $452925.0 (down 86.31% YoY), while the FY2019 annual figure was $452925.0, down 86.31% from the prior year.
  • Preferred Dividend Payments retreated to $452925.0 in Q1 2019 per ALT's latest filing, from $780525.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $2.8 million in Q4 2017 and bottomed at -$64139.0 in Q3 2018.
  • Historically, Preferred Dividend Payments has averaged $750282.7 across 4 years, with a median of $286955.5 in 2016.
  • Annual changes were most pronounced in 2017 — Preferred Dividend Payments soared 2218.34% — and 2018, when it tumbled 103.27%.
  • Altimmune's Preferred Dividend Payments stood at $120986.0 in 2016, then jumped by 2218.34% to $2.8 million in 2017, then slumped by 72.17% to $780525.0 in 2018, then plunged by 41.97% to $452925.0 in 2019.
  • Business Quant data shows ALT's Preferred Dividend Payments at $452925.0 in Q1 2019, $780525.0 in Q4 2018, and -$64139.0 in Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.41 Bn 27.57 Bn - -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn -
10 Altimmune 625.13 Mn 625.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 452,925.00
Dec 31, 2018 780,525.00
Sep 30, 2018 -64,139.00
Jun 30, 2018 700,093.00
Mar 31, 2018 1.89 Mn
Dec 31, 2017 2.80 Mn
Sep 30, 2017 1.96 Mn
Jun 30, 2017 44,713.00
Mar 31, 2017 118,356.00
Dec 31, 2016 120,986.00
Sep 30, 2016 104,548.00
Jun 30, 2016 87,123.00